Caribou Biosciences, Inc.

CRBU · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$28-$54-$40-$35
Dep. & Amort.$1$1$1$1
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$3$0$4
Change in WC-$1$1-$1-$4
Other Non-Cash$3$21$4-$1
Operating Cash Flow-$25-$28-$37-$35
Investing Activities
PP&E Inv.-$0-$0-$1$1
Net Acquisitions$0$0$0$0
Inv. Purchases-$57-$32-$16-$56
Inv. Sales/Matur.$68$57$66$72
Other Inv. Act.$0$0$0-$2
Investing Cash Flow$11$24$49$16
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$3
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0-$0$0$1
Financing Cash Flow$0$0$0$4
Forex Effect$0$0$0$0
Net Chg. in Cash-$14-$4$13-$16
Supplemental Information
Beg. Cash$25$29$16$32
End Cash$11$25$29$16
Free Cash Flow-$25-$29-$38-$36